The FDA told Johnson & Johnson (JNJ) in 1997 that its request to market the antipsychotic drug Risperdal for children was "without any justification." In the following years, J&J's army of ...

Aug. 1, 2002 -- Risperidone was well tolerated and effective in treating behavioral problems in autistic children, according to the results of a multisite, double-blind, randomized trial reported in ...

TITUSVILLE, N.J., Aug. 22 The U.S. Food and DrugAdministration (FDA) today approved RISPERDAL(R) (risperidone) for thetreatment of schizophrenia in adolescents ages 13-17 and for the ...

Risperidone is an antipsychotic with known side effects that clinicians must balance against its benefits for a subset of autistic people. Although it can, for some autistic people, help reduce ...

Use of second-generation antipsychotics like risperidone has been linked to hyperprolactinemia (HPRL), but most studies on antipsychotic-induced serum PRL level variations have been conducted in only ...

Children with autism spectrum disorders (ASDs) often have severe behavioral disturbances including aggression, self-injury and tantrums. Although not included in the diagnostic criteria, these ...

Johnson & Johnson, still reeling from settling two Ohio opioid-related lawsuits for more than $20 million, was slapped with an $8 billion judgment on Tuesday over its antipsychotic drug Risperdal. A ...

A judge on Friday took an axe to a legal award against Johnson & Johnson — chopping the settlement from $8 billion to $6.8 million — in the case of a man who said the company failed to warn consumers ...

Risperdal risperidone: What's the difference? Haloperidol is an antipsychotic medication used to treat schizophrenia, acute psychosis, and tics and vocal utterances of Tourette's syndrome. As a result ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Risperidone (Risperdal) is an atypical ...

TITUSVILLE, N.J., Aug. 22 -- The U.S. Food and Drug Administration (FDA) today approved RISPERDAL(R) (risperidone) for the treatment of schizophrenia in adolescents ages 13-17 and for the short-term ...